Login to Your Account

Financings Roundup

Regulus Files for IPO with Buyers Already Lining Up

By Catherine Shaffer
Staff Writer

Tuesday, August 21, 2012
Hot on the heels of two major partnership deals, Regulus Therapeutics Inc. filed a form S-1 with the SEC for a proposed initial public offering (IPO) for $57.5 million to fund its microRNA pipeline.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription